Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $7.3 million.

  • Treace Medical Concepts' Accumulated Expenses fell 966.91% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 966.91%. This contributed to the annual value of $7.2 million for FY2024, which is 3118.19% down from last year.
  • Latest data reveals that Treace Medical Concepts reported Accumulated Expenses of $7.3 million as of Q3 2025, which was down 966.91% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Accumulated Expenses ranged from a high of $15.2 million in Q1 2024 and a low of $2.4 million during Q2 2021
  • For the 5-year period, Treace Medical Concepts' Accumulated Expenses averaged around $7.0 million, with its median value being $7.1 million (2023).
  • Per our database at Business Quant, Treace Medical Concepts' Accumulated Expenses skyrocketed by 10696.29% in 2021 and then tumbled by 6035.63% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Accumulated Expenses stood at $4.5 million in 2021, then skyrocketed by 69.68% to $7.7 million in 2022, then surged by 36.42% to $10.5 million in 2023, then tumbled by 31.18% to $7.2 million in 2024, then increased by 1.64% to $7.3 million in 2025.
  • Its Accumulated Expenses was $7.3 million in Q3 2025, compared to $7.1 million in Q2 2025 and $6.0 million in Q1 2025.